Vale Dr Nicholas Murphy

It is with great sadness that we announce that our respected friend and colleague, Doctor Nicholas Murphy MBBS, FRACP, FRCPA passed away on 30 July 2025 from recurrent brain cancer.
Nick was a Clinical and Laboratory Haematologist at the Royal Hobart Hospital (RHH) and a valued Member of the ALLG. Joining both RHH and the ALLG in 2013, Nick’s enthusiasm for clinical trial research was fostered at the Royal Melbourne Hospital, Western Hospital and Northern Hospital with the AMLM16 Sorafenib and the CLL07 trials. In landing his role in Hobart, Nick eagerly assumed site Principal Investigator for NHL29 IRIC and MM18 CaTD. Nick featured in the authorship of all of these ALLG trials for his contributions. He was a keen Myeloma Scientific Working Party member, and we remember him fondly for his contributions with ALLG and the Myeloma MSAG. The ALLG was pleased to award Nick his 10-year membership in 2023.
Nick completed his medical training at The University of Melbourne: Austin & Repatriation Medical Centre Clinical School and graduated in 2002. During his training he completed his elective term in Swaziland Africa and also deferred his study to travel abroad. Nick gained his combined FRACP and FRCPA in 2011 and worked for three years as a Consultant Clinical Haematologist, at both Northern and Western Health. During this time, he was also a Laboratory Haematologist for Dorevitch Pathology, Western Health and a Lecturer at the University of Melbourne. In 2013 Nick moved to Tasmania with his family where he took on the role of Consultant Haematologist at Royal Hobart Hospital, working both in laboratory and clinical haematology as well as private practice.
Nick served as the Tasmanian Councillor for the Haematology Society of Australia and New Zealand from 2019 until 2023 when he had to step down for health reasons. He was a greatly respected haematologist as well as a generous and wise friend. Nick was married to Myf and they have 2 teenage daughters, Genevieve and Maggie. Nick’s illness first manifest in 2015. In spite of the major impact this had on his life he returned to work and contributed whole-heartedly until 2023, never allowing his illness to diminish his contributions and never seeking sympathy for his adversity. His legacy will live on with his family, in the many registrars he mentored as well as in the influence he had on his colleagues.
